Cash Position & Operating Runway : As of December 31, 2024, ARS Pharma had cash, cash equivalents, and short-term investments of $314.0 million, with 97,954,172 shares of common stock outstanding. The ...
Monte Rosa announced clinical results from its MRT-6160 Phase 1, single ascending dose / multiple ascending dose study. Details about the ...
1 小时
News-Medical.Net on MSNScientists identify top food sources of prebiotics for better digestionResearchers quantified prebiotic levels in 35 common foods and estimated daily intake in Italians, finding cereal products ...
In a letter to Housatonic Water Works Treasurer James Mercer on Tuesday, March 18, MassDEP representative Andrew Kelly writes ...
10 小时
Fin vs Fin on MSNBetter U Weight Loss Program: Honest Review & GuideBetter U Weight Loss Overview Cost: $298 or $397 per month What’s prescribed: Compounded semaglutide and tirzepatide, Ozempic ...
DelveInsight's "DARZALEX Market Size, Forecast, and Market Insight Report" highlights the details around DARZALEX, a human ...
MacroGenics (NASDAQ: MGNX) Q4 2024 Earnings Call Mar 20, 2025, 4:30 p.m. ET ...
For as much success as BMW has seen as a German auto manufacturer or otherwise, not every vehicle has been a massive hit with its audience.
13 小时
网上车市 on MSNMG4改款公布,车身大一号,续航也提升?MG 近日在官方微博公布,其改款 MG4 EV 的无伪装外观照,并强调是 2025 年 MG 品牌首款全球车,外观上比起 MG4 更为圆润,根据工信部申报信息来看车长变为 4,395mm、轴距 2,750mm,比起现行款 MG4 的车长 ...
DARZALEX has significant market potential as a leading monoclonal antibody for multiple myeloma treatment. Its approval in various combinations for both newly diagnosed and relapsed/refractory ...
Growth Strategy Leveraging Both Internal and External Brand Assets Across Multiple Categories Announces First VLN® Partner Brands with Smoker Friendly Ready for Shipment in Q2 2025, Additional ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果